STAGE IVB THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8
Clinical trials for STAGE IVB THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVB THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVB THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise against aggressive thyroid cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab to standard chemotherapy can help people with advanced anaplastic or poorly differentiated thyroid cancer live longer. About 50 participants will receive different drug combinations based on their cancer's geneti…
Matched conditions: STAGE IVB THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
New drug combo shows promise against rare, aggressive thyroid cancer
Disease control OngoingThis study tests a combination of two drugs, lenvatinib and pembrolizumab, in 25 people with advanced anaplastic thyroid cancer that cannot be removed by surgery or has spread. Lenvatinib blocks enzymes that help cancer cells grow, while pembrolizumab helps the immune system atta…
Matched conditions: STAGE IVB THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC